Check Point Software Technologies.../ IL0010824113 /
2024-03-19 2:34:22 PM | Chg. -1.1700 | Volume | Bid2:34:34 PM | Ask2:34:34 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
165.3100USD | -0.70% | 12,617 Turnover: 1.9 mill. |
165.0500Bid Size: 200 | 165.8100Ask Size: 400 | 20.7 bill.USD | - | 25.95 |
GlobeNewswire
1:30 PM
SP Plus Corporation Offers Complimentary Bags® Remote Check-in and Bag Drop Services at Harry Reid I...
GlobeNewswire
1:00 PM
BioAtla to Announce Fourth Quarter and Full-Year 2023 Financial Results and Provide Business Highlig...
GlobeNewswire
03-18
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M...
GlobeNewswire
03-18
Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Eva...
GlobeNewswire
03-14
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
GlobeNewswire
03-14
Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ...
GlobeNewswire
03-12
KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 V...
GlobeNewswire
03-12
Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Ac...
GlobeNewswire
03-11
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire
03-07
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Upda...
GlobeNewswire
03-06
Introducing Check Point Harmony SaaS: The Cutting-Edge Solution for SaaS Threat Prevention
GlobeNewswire
03-06
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
GlobeNewswire
03-06
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire
03-06
Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire
03-05
ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annua...
GlobeNewswire
03-05
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Trea...
GlobeNewswire
03-05
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science...
GlobeNewswire
03-04
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024